Compare AbbVie Inc (ABBV) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Motorola Solutions Inc — how do they compare? AbbVie Inc trades at $253.76 (market cap $449.91B), while Motorola Solutions Inc trades at $418.78 (market cap $70.42B). The key difference: AbbVie Inc is far larger — about 6.4× Motorola Solutions Inc's market cap, and AbbVie Inc pays the higher dividend (2.72%). Which is the better fit depends on your goals.
| ABBV | MSI | |
|---|---|---|
Market Cap | $449.91B | $70.42B |
Sector | Health | Technology |
52-Week High | $261.07 | $490.30 |
52-Week Low | $184.85 | $363.83 |
Enterprise Value | $513.38B | $79.12B |
Dividend Yield | 2.72% | 1.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $254.44, showing slight daily weakness but maintaining a bullish technical structure with strong institutional support. The company has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $2.65 exceeding the $2.59 estimate. Revenue growth is accelerating, reaching $61.16B in 2025, while the immunology portfolio (Skyrizi, Rinvoq) successfully offsets Humira declines. Analyst consensus remains strongly positive with 68% buy ratings and a $266.33 price target.
The outlook is constructive with robust pipeline developments and dividend growth, though elevated valuation multiples (P/E 124.83, P/B 245.29) and looming patent cliffs in the 2030s present risks. Net income margin compression from 20.38% in 2022 to 6.9% in 2025 requires monitoring, but strong cash generation ($19.03B operating cash flow) supports continued shareholder returns.
Motorola Solutions (MSI) trades at $424.21, up 0.37% with strong technical momentum and bullish analyst sentiment. The company demonstrates robust fundamentals with 17.61% net margins and consistent earnings beats, supported by recent AI expansion initiatives and a $1.5B acquisition of D-Fend Solutions. Revenue growth has accelerated from $9.1B in 2022 to $11.7B in 2025.
MSI presents a compelling growth story with AI-driven public safety expansion and strong institutional support, though elevated valuation multiples and increased capital expenditures pose risks. The consensus price target of $512.33 suggests 21% upside potential, supported by 71% analyst buy ratings and positive technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
